Combined determination of B-type natriuretic peptide and high-sensitivity troponin I in the postmortem diagnosis of cardiac disease

• Published in: Forensic science, medicine, and pathology Vol. 15; no. 4; pp. 528 - 535
• Main Authors: Bañón, Rafael, Hernández-Romero, Diana, Navarro, Esperanza, Pérez-Cárceles, María Dolores, Noguera-Velasco, José Antonio, Osuna, Eduardo
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.12.2019; Springer
• Subjects: Biomarkers - blood; Case-Control Studies; Creatine kinase; Creatine Kinase, MB Form - blood; Criminology and Criminal Justice; Death, Sudden, Cardiac - etiology; Diagnosis; Discriminant Analysis; Enzymes; Female; Forensic Medicine; Forensic Pathology; Heart; Heart failure; Heart Failure - blood; Heart Failure - diagnosis; Humans; Male; Medicine; Medicine & Public Health; Middle Aged; Myocardial Ischemia - blood; Myocardial Ischemia - diagnosis; Natriuretic Peptide, Brain - blood; Natriuretic peptides; Original Article; Pathology; Postmortem Changes; Prognosis; Troponin I - blood; High-sensitivity cardiac troponin, ß-type natriuretic peptide; Cardiac disease; Postmortem diagnosis
• ISSN: 1547-769X; 1556-2891
• DOI: 10.1007/s12024-019-00150-1

Cardiac disease is the most common cause of sudden death in Western countries. It is known that high-sensitivity troponin I (hs-cTnI), widely used for detection of myocardial injury, is a sensitive biochemical marker. B-type natriuretic peptide (BNP) is a reliable tool for diagnosing heart failure, and for establishing prognosis or disease severity. We aimed to evaluate the diagnostic efficacy of the postmortem determination of BNP in serum alone or in addition to other biomarkers, such as hs-cTnI and MB isoenzyme of creatine kinase (CK-MB), to ascertain whether its determination improves the post-mortem diagnosis of heart failure-associated causes of death. This study involved 133 cadavers with a mean age of 58.2 (± 17.6) years and a mean postmortem interval of 12.8 (±6.6) h. Cases were assigned into two diagnostic groups, according to the cause of death: cardiac deaths ( N  = 62) and control ( N  = 71). In the cardiac group, two categories were established according to morphological features of the heart: ‘ischemic deaths’ ( N  = 39), and ‘congestive heart’ ( n  = 23). Both hs-cTnI and BNP were useful in diagnosing cardiac deaths, whereas CK-MB did not have any diagnostic relevance. hs-cTnI is higher in cases which acute ischemia as the principal pathology, while the presence of high BNP values is significantly related with chronic cardiac situations with significant ventricular overload. Our findings show that postmortem determination of hs-cTnI and BNP provides valuable information; hs-cTnI is useful for diagnosis of cardiac deaths, mainly with ischemic implications, and BNP gave better results for the diagnosis of congestive heart failure.